Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy?
covid-19, SARS-CoV-2, Hydroxychloroquine, type I interferon, azithromycin
Michel Brazier, Aurélien Mary, Aurélien Mary, Lucie Hénaut, Jean-Luc Schmit, Jean-Luc Schmit, Jean-Philippe Lanoix, Jean-Philippe Lanoix, Michel Brazier